In a 23‑week pregnant woman with an uncomplicated pregnancy and a mother who has type 2 diabetes, what is the appropriate gestational diabetes screening test?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 16, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Gestational Diabetes Screening at 23 Weeks Gestation

This patient should undergo a 75-gram oral glucose tolerance test (OGTT) at 24–28 weeks gestation, not at her current 23-week visit. 1, 2

Why Not Screen at 23 Weeks?

  • The 24–28 week window is mandatory because this period corresponds to peak pregnancy-related insulin resistance, when gestational diabetes most frequently manifests and when diagnostic criteria have been validated. 1, 2

  • The IADPSG and Carpenter-Coustan diagnostic thresholds should not be applied before 24 weeks gestation, as they were derived exclusively from data collected in the later half of pregnancy. 1, 3

  • The HAPO study, which established current diagnostic cut-offs, evaluated glucose-outcome relationships specifically at 24–28 weeks, not earlier. 1, 2

Does Family History of Type 2 Diabetes Change the Timing?

No—a single first-degree relative with diabetes does not justify early screening at 23 weeks. 2

  • Early screening at the first prenatal visit (12–14 weeks) is reserved for very high-risk women with marked obesity (BMI ≥30 kg/m²), prior gestational diabetes, glycosuria, or multiple first-degree relatives with early-onset diabetes. 2, 3

  • A family history of type 2 diabetes in one parent elevates risk but places this patient in the average-risk category, which requires standard screening at 24–28 weeks only. 2, 3

Why the Other Options Are Incorrect

A. Hemoglobin A1C at This Visit

  • HbA1c is not recommended for gestational diabetes screening due to poor sensitivity and specificity for detecting GDM. 1, 2

  • HbA1c may only be used to identify pre-existing type 2 diabetes early in pregnancy (threshold ≥6.5%), not for routine GDM screening. 1, 2

B. Random Blood Sugar at This Visit

  • Random plasma glucose measurements are not validated or recommended for GDM screening. 2

  • Random glucose ≥200 mg/dL with symptoms indicates overt diabetes, not screen-positive GDM, and would require immediate diagnostic confirmation with fasting glucose or HbA1c. 1, 2

D. 3-Hour Glucose Tolerance Test at 28–32 Weeks

  • The 3-hour 100-gram OGTT is a diagnostic test used only in the two-step approach after a positive 50-gram glucose challenge test; it is not a primary screening tool. 1, 2

  • The timing of 28–32 weeks is suboptimal; the recommended window is 24–28 weeks to allow timely intervention before the third trimester. 1, 2

The Correct Answer: C. 75-Gram OGTT at 24–28 Weeks (Corrected Timing)

The patient should return at 24–28 weeks for a 75-gram OGTT using the one-step approach endorsed by the American Diabetes Association and International Association of the Diabetes and Pregnancy Study Groups. 1, 2

Test Procedure

  • Perform after an 8–14 hour overnight fast with plasma glucose measured at fasting, 1 hour, and 2 hours. 1, 3

  • Diagnosis requires any single abnormal value:

    • Fasting ≥92 mg/dL (5.1 mmol/L) 1, 2
    • 1-hour ≥180 mg/dL (10.0 mmol/L) 1, 2
    • 2-hour ≥153 mg/dL (8.5 mmol/L) 1, 2
  • Patients should consume ≥150 grams of carbohydrate daily for at least 3 days before the test to ensure adequate glycogen stores. 3

Alternative Two-Step Approach

  • The American College of Obstetricians and Gynecologists supports a two-step strategy:

    • Step 1: 50-gram non-fasting glucose challenge test at 24–28 weeks; if 1-hour glucose ≥130–140 mg/dL, proceed to Step 2. 1, 2
    • Step 2: 100-gram OGTT (fasting) with diagnosis requiring at least two abnormal values: fasting ≥95 mg/dL, 1-hour ≥180 mg/dL, 2-hour ≥155 mg/dL, 3-hour ≥140 mg/dL. 1, 2
  • ACOG notes that in clinical practice a single elevated value may be used for diagnosis, although traditional Carpenter-Coustan criteria require two abnormal values. 1, 3

Critical Pitfall to Avoid

Do not postpone screening beyond 28 weeks. The 24–28 week window enables timely intervention to reduce preeclampsia, macrosomia, shoulder dystocia, and neonatal hypoglycemia—outcomes that worsen with delayed diagnosis. 1, 2

Postpartum Follow-Up

  • All women diagnosed with GDM must undergo a 75-gram OGTT at 4–12 weeks postpartum using non-pregnancy diagnostic criteria to detect persistent diabetes or prediabetes. 1, 4

  • Lifelong diabetes screening every 3 years is mandatory because women with prior GDM have a 3.4-fold increased risk of developing type 2 diabetes. 1, 4

  • Women with postpartum prediabetes should receive intensive lifestyle intervention or metformin therapy to prevent progression to overt diabetes. 1, 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Screening for Gestational Diabetes in Pregnant Women

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guidelines for Oral Glucose Tolerance Testing in Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Diagnosis and Management of Gestational Diabetes Mellitus

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

A 23‑week pregnant G2P1 with normal evaluation, O‑positive blood type, and a mother with type 2 diabetes is concerned about developing diabetes; what is the most appropriate next step in management?
In a pregnant woman diagnosed with gestational diabetes mellitus, when are repeat 75‑g oral glucose tolerance tests indicated?
What is the recommended screening test for gestational diabetes mellitus (GDM) in a pregnant woman at 23 weeks gestation with a family history of Type 2 Diabetes Mellitus (T2DM)?
In a 23‑week pregnant woman with a mother who has type 2 diabetes mellitus, which test is appropriate for gestational diabetes mellitus screening?
What is the recommended screening protocol for gestational diabetes mellitus, including timing, glucose challenge test thresholds, diagnostic oral glucose tolerance test criteria, and early screening indications for high‑risk pregnant women?
What are the appropriate investigations and management for a 17‑year‑old without a diabetes diagnosis who has an HbA1c of 42 mmol/mol (≈6 %) and laboratory findings consistent with iron‑deficiency anemia (low serum iron, low‑normal ferritin, elevated transferrin, low transferrin saturation, microcytic hypochromic red cells)?
What is the most appropriate next step in management for a 37‑year‑old woman with left knee pain worsened by descending stairs and squatting, recent 10 K training, bilateral over‑pronation, and no red‑flag findings?
What is the likelihood that an acute ischemic stroke occurred despite a normal diffusion‑weighted imaging (DWI) MRI on the day of symptom onset, with fluid‑attenuated inversion recovery (FLAIR) changes appearing four days later?
How should patients exposed to lead‑containing house paint be evaluated and managed, including screening, blood lead level thresholds, environmental remediation, chelation therapy, and special considerations for children, adults, and pregnant women?
What additional recommendations should be made for a 49‑year‑old male with chronic kidney disease (CKD) stage IV not on dialysis, currently taking ferrous fumarate, keto‑analogue supplement, sevelamer, amlodipine, nebivolol, cinacalcet (Cinalcet), febuxostat, and sulodexide, who is being evaluated for kidney transplantation?
Should a 52-year-old asymptomatic former smoker with normal blood pressure, hemoglobin A1c (HbA1c) 5.4%, BMI 29 kg/m², HDL cholesterol 50 mg/dL, LDL cholesterol 92 mg/dL, total cholesterol 104 mg/dL, and low 10-year atherosclerotic cardiovascular disease (ASCVD) risk undergo abdominal aortic aneurysm screening or carotid artery ultrasound?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.